PBYI vs RVTY · P/E 4.3, rev $56.5M vs P/E 42, rev $1.44B
Puma Biotechnology Inc (PBYI) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
PBYI currently screens at market cap $165.3M and trailing P/E 4.3. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the PBYI and RVTY stock pages for the full models.
Not investment advice.